Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer, A Multicenter, Randomized, Phase III Clinical Trial

NCT04547907 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT04547907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04547907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer, A Multicenter, Randomized, Phase III Clinical Trial
Lead sponsor
Henan Cancer Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
September 18, 2020
Completion date
December 31, 2024
Enrollment
688 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer,her2-positive